Company / Net Income
Tyra Biosciences, Inc. Net Income History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$86.5M
FY2024
5-year range
-$86.5M / -$9.3M
FY2020-FY2024
Trend
-25.1%
vs FY2023
Sector context
#104 of 216
Health Care
What the data says
At -$86M, Tyra Biosciences, Inc.'s net income ranks #104 of 216 in the Health Care sector. Net Income has declined for 4 consecutive years, from -$9M in FY2020 to -$86M in FY2024.
Based on SEC 10-K filings.
-$86M in FY2024.
Declined from -$55M to -$86M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#104 of 216 in Health CareTop 48% of 216This company -$86.5M Sector average $454.3M
▼
-119.0% below sector average
Key checks
Key Insights
- Tyra Biosciences, Inc.'s net income has declined for 4 consecutive years.
- In FY2024, net income decreased 25.1% year-over-year.
- Ranks #104 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$86.5M | -25.1% |
| FY2023 | -$69.1M | -25.0% |
| FY2022 | -$55.3M | -110.4% |
| FY2021 | -$26.3M | -181.6% |
| FY2020 | -$9.3M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026